Veranova
| Formerly | J.F. Macfarlan Ltd (1780–1829) J.F. Macfarlan and Co Ltd. (1830–1961) Edinburgh Pharmaceutical Industries (1962) Macfarlan Smith Ltd (1963–1989) Meconic (1990–2000) Johnson Matthey Health (2001–2022) |
|---|---|
| Company type | Limited Partnership |
| Industry | Contract development and manufacturing organization (CDMO) |
| Headquarters | 25 Patton Road, Devens, MA 01434 |
Area served | Worldwide |
Key people | Mike Riley (CEO) |
| Website | https://veranova.com/ |
Veranova, L.P. (formally Johnson Matthey Health) is an American multinational contract development and manufacturing organization (CDMO) based in Devens, MA, with operations in North America and Europe.
The company focuses on the process, development, and manufacturing of active pharmaceutical ingredients (APIs), particularly specialty and highly regulated, complex chemistries. It has two divisions, Generics and Originators. Its specialized drug development and manufacturing technologies and expertise in the pharmaceutical and biotechnology industries span the drug development lifecycle.
Johnson Matthey Health was purchased in 2022 by Altaris Capital Partners for £325 million (JM retaining 30% equity) and rebranded to become Veranova; the name originates from the combined Latin words ‘vērus’, meaning ‘true’, and ‘nŏvus’, meaning ‘new’.